Major investors Nvidia and Novo Holdings A/S have fully exited their positions in Recursion Pharmaceuticals (NasdaqGS:RXRX), ...

If you are trying to figure out whether Recursion Pharmaceuticals is attractively priced or a high risk speculation, a useful ...

Cathie Wood's ARK Invest bought Recursion Pharmaceuticals and CRISPR Therapeutics while selling PagerDuty, Teradyne, and Salesforce on8, 2026.

For example, one of the things about modern English that would most strike a time traveler from the past is the frequency of “I was like …” among younger speakers, as in “And I was like ‘You don’t ...

When artificial intelligence (AI) chip maker NVIDIA Corporation (NVDA) heads for the exit, investors instinctively glance at the door. In its latest 13F filing, the chip giant disclosed that it had ...

The impulse at the root is ancient and admirable. In Jewish tradition: tikkun olam—literally, repair of the world. In its kabbalistic form, it described uncovering divine sparks hidden in ordinary ...

Recursion Pharmaceuticals (RXRX) ended the recent trading session at $3.53, demonstrating a +2.02% change from the preceding day's closing price. This move outpaced the S&P 500's daily gain of ...

Detailed price information for Crispr Therapeutics Ag (CRSP-Q) from The Globe and Mail including charting and trades.

Did you know Wayland is a place you can visit?

Within days of release, Clawdbot became a sensation, delivering both the promise of productivity and a security nightmare, while giving a glimpse of our agent-run future writes Satyen K. Bordoloi ...

Following a chance encounter on the train, Polish conceptual artist Agnieszka Kurant welcomed me into her multidisciplinary universe, where anthropology meets art meets sociology meets philosophy ...

A prophetic analysis of artificial intelligence through Genesis 11 revealing how AI mirrors Babel and advances a centralized global system foretold in Scripture.